China Jo jo Drugstores Holdings Inc   (CJJD)
Other Ticker:  
Price: $0.1920 $0.01 3.393%
Day's High: $0.207 Week Perf: 11.69 %
Day's Low: $ 0.19 30 Day Perf: -7.83 %
Volume (M): 414 52 Wk High: $ 8.31
Volume (M$): $ 79 52 Wk Avg: $1.83
Open: $0.20 52 Wk Low: $0.17

 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 10
 Employees 3,377
 Revenues (TTM) (Millions $) 149
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

China Jo Jo Drugstores Holdings Inc
China Jo Jo Drugstores Holdings Inc.
(CJJD) is a leading pharmaceutical retail chain in China, offering a wide range of products and services to customers, including prescription and over-the-counter drugs, health and wellness products, traditional Chinese medicine products, medical equipment, health assessments and consultations, and disease management services.
Founded in 2004, CJJD operates a network of over 200 retail pharmacies in 29 provinces and municipalities in China, as well as an online pharmacy platform.
The company also provides supply chain management services to other pharmacies and healthcare providers in China.
The company's retail pharmacies are strategically located in high-traffic areas such as shopping malls, supermarkets, and hospitals, providing easy access to customers.
The company follows a customer-centric approach, providing personalized and professional services to its customers, such as health assessments, consultations, and disease management programs.
CJJD has implemented various digital initiatives to enhance its retail operations, such as online ordering, home delivery, mobile payments, and data analytics.
The company's online pharmacy platform provides customers with a convenient way to purchase medicines and health products and access health-related information.
In addition to its retail operations, CJJD has established partnerships with leading pharmaceutical manufacturers in China and internationally to improve its product offerings and supply chain efficiency.
The company also invests in research and development to introduce innovative health products and services to the market.
CJJD has received numerous awards and recognitions for its contribution to the healthcare industry in China, including being named one of the "Top 50 Most Valuable Brands in Chinese Retail Pharmacy Industry" and "China's Top 100 Chain Drugstores" by China Chain Store & Franchise Association.
Overall, China Jo Jo Drugstores Holdings Inc.
is a highly reputable and innovative pharmaceutical retail chain in China, providing high-quality products and services to its customers and contributing to the development of the healthcare industry in China.

   Company Address: Hai Wai Hai Tongxin Hangzhou City 310008
   Company Phone Number: 571-88219579   Stock Exchange / Ticker: NASDAQ CJJD
   CJJD is expected to report next financial results on June 14, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Bimi International Medical Inc

Bimi International Medical Inc Continues to Surge with Record Revenue of $5.5 Million in Q2 2023

Bimi International Medical Inc, a renowned medical company, has recently announced its impressive financial results for the fiscal period ending on June 30, 2023. The company generated a substantial revenue of $5.557666 million, which indicates a significant growth in its operations. Moreover, Bimi International Medical Inc also exhibited an improving profit margin, with a net margin of 18.97% and an operating margin of 23.38%.
One notable aspect of their financial statement is the decline in net earnings compared to the corresponding period the previous year. While Bimi International Medical Inc recorded no profits in the previous period, the company experienced a decline in net earnings, which amounted to $1.054 million in the current period. Although this decline might seem alarming at first, the company's overall performance and the growth in revenue indicate that Bimi International Medical Inc is still on a positive trajectory.

Cosmos Health Inc

Cosmos Health Inc. Demonstrates Impressive Revenue Growth in Q3 2023 Despite Minor Deficit

Cosmos Health Inc, a company trading on the NASDAQ, has experienced a decline in share prices over the past month, along with a significant drop compared to its 52-week average. However, recent positive developments have been observed, including an increase in COSM shares over the last five trading days. These contrasting trends and the third-quarter financial results indicate some challenges for Cosmos Health Inc, which may have ramifications for the company's future prospects.
1. Share Performance:
- Cosmos Health Inc shares have witnessed a decline of -2.7% over the past 30 days, suggesting a loss of investor confidence.
- COSM shares, on the other hand, have shown growth of 3.85% over the last five trading days, implying a short-term recovery for the company.

Trees Corporation

Trees Corporation Boasts Remarkable 29.41% Surge in Revenue for Q3 2023, Shining in the Pharmacy Services and Retail Drugstore Industry

Financial News Report: Trees Corporation Reports Improved Earnings and Revenue Growth in Q3 2023
Trees Corporation, a leading Pharmacy Services and Retail Drugstore company, recently announced its financial results for the third quarter of 2023. The company showed significant improvements in earnings per share (EPS) and revenue growth compared to the same period in the previous year.
During the third quarter of 2023 earnings season, Trees Corporation reported a decrease in loss per share of $0.01, compared to a loss of $0.03 per share in the same period a year before. This represents a positive development for the company and demonstrates its efforts to reduce losses. Additionally, the EPS improved from -$0.02 in the preceding financial reporting period.

Petiq Inc

Astonishing Financial Rebound: PetIQ Inc. Transforms Losses into Gains, Embarks on a Path of Success

the third quarter financial results of PetIQ Inc. (NASDAQ: PETQ), a prominent pet medication and wellness company, have been released, investors are provided with substantial evidence of the company's improving financial health. According to the report for the July to September 30, 2023, time-frame, PetIQ Inc. has achieved remarkable improvements in various financial indicators.
First and foremost, the company's earnings turned positive in this period, with a significant increase from a loss of $-1.68 per share to a gain of $0.02 per share compared to the same period last year. This represents a remarkable recovery and reflects the successful implementation of the company's strategic initiatives.

Cardinal Health Inc

Cardinal Health Inc's Earnings Soar by $32 Million Thanks to Tax Provisions

Cardinal Health Inc (CAH) experienced a challenging period in terms of earnings per share (EPS), with a significant decline of -95% to $0.02 per share in the first quarter of 2024. Despite this, the company saw impressive revenue growth of 10.403% to $54.76 billion compared to the same reporting period the previous year.
In the Pharmacy Services and Retail Drugstore sector, Cardinal Health Inc's revenue growth outpaced that of its contemporaries. Two-thirds of businesses in this industry experienced a top-line growth of 9.65% relative to the previous year.


China Jo Jo Drugstores Holdings Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com